Cellkraft Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 01-01-2025
- Paid Up Capital ₹ 1.00 M
as on 01-01-2025
- Company Age 6 Year, 9 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 3.46 M
as on 01-01-2025
- Revenue 4228.88%
(FY 2021)
- Profit 145.50%
(FY 2021)
- Ebitda 197.06%
(FY 2021)
- Net Worth 38.48%
(FY 2021)
- Total Assets 61.15%
(FY 2021)
About Cellkraft Biotech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹3.46 M.
Siddharth Dubey and Ashutosh Acharya serve as directors at the Company.
- CIN/LLPIN
U74999KA2018PTC111938
- Company No.
111938
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Apr 2018
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Cellkraft Biotech Private Limited offer?
Cellkraft Biotech Private Limited offers a wide range of products and services, including Medical Laboratory Instruments, Corona Test Kit.
Who are the key members and board of directors at Cellkraft Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Siddharth Dubey  | Director | 04-Apr-2018 | Current |
Ashutosh Acharya  | Director | 04-Apr-2018 | Current |
Financial Performance of Cellkraft Biotech.
Cellkraft Biotech Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 4228.88% increase. The company also saw a substantial improvement in profitability, with a 145.5% increase in profit. The company's net worth Soared by an impressive increase of 38.48%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cellkraft Biotech?
In 2021, Cellkraft Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 19 Sep 2022 | ₹2.00 M | Open |
Syndicate Bank Creation Date: 03 Apr 2019 | ₹0.50 M | Open |
Syndicate Bank Creation Date: 06 Aug 2018 | ₹0.96 M | Open |
How Many Employees Work at Cellkraft Biotech?
Unlock and access historical data on people associated with Cellkraft Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cellkraft Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cellkraft Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
